J. O’Callaghan

Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome

E. Buchser, E. Eisenberg, Krishna Kumar, 2007, Pain.

Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

F. Shanahan, J. K. Collins, M. Bennett, 1999, Clinical Diagnostic Laboratory Immunology.

THE EFFECTS OF SPINAL CORD STIMULATION IN NEUROPATHIC PAIN ARE SUSTAINED: A 24‐MONTH FOLLOW‐UP OF THE PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER TRIAL OF THE EFFECTIVENESS OF SPINAL CORD STIMULATION

E. Buchser, E. Eisenberg, Krishna Kumar, 2008, Neurosurgery.

Quality of life, resource consumption and costs of spinal cord stimulation versus conventional medical management in neuropathic pain patients with failed back surgery syndrome (PROCESS trial)

Ron Goeree, Mark J Sculpher, Andrea Manca, 2008, European journal of pain.

Recommendations for patient selection in spinal cord stimulation

J. O’Callaghan, J. Salmon, P. Teddy, 2011, Journal of Clinical Neuroscience.

Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)

M. Sculpher, E. Buchser, E. Eisenberg, 2005, Neuromodulation : journal of the International Neuromodulation Society.

Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome

E. Buchser, E. Eisenberg, Krishna Kumar, 2007, Pain.